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Abstract
Background:  To our knowledge we report the first case of percutaneous mechanical
thrombectomy used for the treatment of massive pulmonary embolism in the United Kingdom.
Pulmonary embolism is a common disease process but can be difficult to diagnose. Massive
pulmonary embolism presenting with profound hypotension, however, is rare. Both phenomena
carry with them significant mortality. Traditionally those patients suffering haemodynamic
compromise from pulmonary embolism are treated with intravenous or catheter-directed
thrombolysis. When this is contraindicated surgical embolectomy or mechanical techniques via a
right heart catheter are alternative options. The former is well established but the latter is less
commonly utilised in clinical practice. Our aim is to highlight the effectiveness and relative safety of
percutaneous mechanical thrombectomy as a therapeutic tool in massive pulmonary embolism.
Case presentation: A 70 year-old gentleman presented with a 4-month history of dry cough and
general malaise. Clinical examination along with routine chest radiograph confirmed a left pleural
effusion which was drained. Computed tomography of the chest, abdomen and pelvis revealed a
left renal mass consistent with renal cell carcinoma plus multiple metastatic subpleural nodules.
Following planned thoracoscopy and pleural biopsy the patient became acutely dyspnoeic and
hypotensive. Relevant investigations including computed tomography pulmonary angiogram
confirmed a large saddle embolus extending in to the lobar branches of both left and right
pulmonary arteries. There were several relative contraindications to thrombolysis and so the
patient proceeded to have percutaneous mechanical thrombectomy with excellent results. The
patient made a full recovery from the acute episode and was discharged home on warfarin with a
view to planned cyto-reductive nephrectomy.
Conclusion: We illustrate here that percutaneous mechanical thrombectomy can be a safe and
effective method of treating massive pulmonary embolism when thrombolysis is relatively
contraindicated. It may also be of use as an adjuvant therapy in those patients able to receive
thrombolysis. In the future further evaluation involving a larger cohort of subjects is necessary to
determine whether this treatment is superior to surgical embolectomy when thrombolysis cannot
be performed.
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Background
Pulmonary embolism (PE) is a common but under-diag-
nosed disease process with an estimated incidence of
about 60–70 per 100 000 of the general population.[1]
Massive PE, however, characterised by circulatory collapse
is rare and as such randomised controlled trials (RCT) on
its optimal management are lacking. Indeed only one RCT
comparing thrombolysis to heparin in PE with systemic
hypotension exists with only 8 patients enrolled.[2] Here
the trial was stopped early since all 4 patients throm-
bolysed survived whereas those receiving heparin died.
Despite a lack of robust data British Thoracic Society
(BTS) guidelines published in 2003 clearly recommend
the use of thrombolysis in massive PE; the earlier the bet-
ter.[3] The BTS guidelines go on to state that if there are
absolute contraindications to thrombolysis or in cases of
failed thrombolysis surgical embolectomy or mechanical
techniques via a right heart catheter should be considered.
The former is well-established. The latter technique is
lesser-known despite several successful reports from vari-
ous authors. We describe how percutaneous mechanical
thrombectomy can be a viable alternative to surgical
embolectomy for the treatment of massive PE when
thrombolysis is contraindicated. Our aim here is to high-
light the availability of this treatment modality to a wider
medical forum and so fully establish this technique along-
side pulmonary embolectomy.
Case presentation
A 70 year-old male presented with a 4-month history of
dry cough and general malaise. He had had a right arm
melanoma excised 5 months previously but otherwise
had no significant medical history. Clinical examination
revealed a left pleural effusion confirmed by chest radio-
graph which subsequently drained blood-stained fluid
positive for reactive mesothelial cells and lymphocytes.
Cytology was negative for malignant cells. Computed
tomography (CT) of his thorax and abdomen undertaken
just prior to discharge from hospital revealed a left renal
mass consistent with renal cell carcinoma (RCC) and mul-
tiple bilateral subpleural nodules. Renal function was nor-
mal at this stage.
The patient was electively re-admitted a week later for
planned thoracoscopy and pleural biopsy. Biopsy con-
firmed the subpleural nodules to be metastatic RCC
deposits. Following repeat chest drain insertion the
patient collapsed some hours later and became acutely
dyspnoeic with oxygen saturations of 82% on room air
and a systolic blood pressure of 96 mmHg. There was no
clinical evidence of lower limb deep vein thrombosis.
Arterial gases confirmed type I respiratory failure and an
electrocardiogram revealed a sinus tachycardia with new
right bundle branch block. Subsequent CT pulmonary
angiogram (CTPA) demonstrated a large saddle embolus
with thrombus extending into the lobar branches of both
main pulmonary arteries (Fig. 1). Massive PE was diag-
nosed and in view of its acute setting and the patient being
in extremis the origin of the PE was not sought at this
stage. Moreover a team of chest physicians; oncologists
and urologists concluded that with the combination of
neoplastic disease; a recent biopsy and a chest drain in-
situ thrombolysis would be deleterious to the patient.
Intravenous heparin was commenced whilst a cardiology
opinion was sought to explore the possibility of percuta-
neous intervention. We as a faculty had no previous expe-
rience of using percutaneous mechanical thrombectomy
(PMT) for dealing with massive PE at the time. The lead
cardiologist was asked to review the patient with a view to
endovascular intervention by a chest physician who
wanted to exhaust all the options available. The cardiolo-
gist had remembered a case in the literature where the
AngioJet system had been used to treat massive PE and
from this a consensus decision was reached to pursue PMT
as a definitive therapy for the patient.
We proceeded to rheolytic thrombectomy using the
AngioJet system (Possis Medical, Minneapolis, MN).
Access was gained via 5-French (F) and 10F sheaths into
the right femoral vein. A 4F sheath was also introduced
into the right femoral artery for blood pressure monitor-
ing. We confirmed the absence of thrombus in the inferior
vena cava (IVC) angiographically before proceeding with
right heart catheterisation. A 0.035-inch guidewire was
placed in the right ventricle over which a 5F multipur-
pose-1 (MP-1) diagnostic catheter was fed. Pulmonary
angiography via this catheter revealed filling defects in
both pulmonary arteries (Fig. 2, Additional file 1). A tem-
porary pacing wire was then placed in the right ventricular
apex via the 5F sheath to protect the patient from bradyar-
rhythmia.[4] Mean pulmonary artery pressure was meas-
ured at 35 mmHg.
Thrombectomy was performed using a 6F AngioJet
Xpeedior catheter directed to both main pulmonary arter-
ies via a 9F MP-1 catheter in the right ventricle (Fig. 3).
This was undertaken through the 10F sheath in the right
femoral vein. The AngioJet system was used for a total of
2 minutes and 10 seconds and selective pulmonary angi-
ograms revealed significant reduction in thrombus bur-
den from both left and right pulmonary arteries with
significant restoration of blood flow (Fig. 4, Additional
file 2). A quantitative measure of perfusion improvement
was not assessed due to our relative inexperience with this
procedure. Clinically, however, as perfusion returned to
each main vessel the patient suffered what appeared to be
a pre-syncopal episode on both occasions although all
observations including heart rate, blood pressure and oxy-
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this occurred remains unclear. The entire process took a
total of 1 hour and 35 minutes and required 90 ml of con-
trast. Heart rate remained within normal range through-
out. Following thrombectomy the collection bag could be
seen to contain a significant amount of thrombus material
(Fig.5).
Both the temporary wire and arterial sheath were left in
situ overnight and the patient remained on intravenous
heparin. The chest drain was subsequently removed and
the patient was off supplemental oxygen within 3 days.
Ultrasound of the abdomen and pelvis on day 2 post rhe-
olytic thrombectomy was essentially normal and showed
patent IVC, hepatic, portal and renal veins. Despite this a
prophylactic IVC filter was inserted in preparation for
planned cyto-reductive nephrectomy in approximately six
weeks and subsequent immunotherapy. Following inser-
tion of the IVC filter the patient was warfarinised and then
discharged home.
Conclusion
PMT devices are designed to achieve rapid clearance of
occlusions in large arteries, veins and bypass grafts. In
massive PE the rationale behind PMT is the rapid relief of
central pulmonary obstruction. PMT devices form a heter-
ogeneous group and vary in terms of mechanism of
action, efficacy, safety, and costs. Essentially, however,
there are currently three available catheter thrombectomy
techniques: aspiration thrombectomy, fragmentation
thrombectomy, and rheolytic thrombectomy.[5] A
detailed description of each technique along with their
corresponding catheters is beyond the scope of this case
study and has already been clearly documented in the lit-
erature.[6] Our choice of PMT device in this particular sce-
nario owed mainly to a specific recollection of its
application in massive PE from the literature as opposed
to any previous experience using it.[7]
The AngioJet rheolytic thrombectomy catheter removes
thrombus by use of the Bernoulli principle. It has a dou-
ble-lumen shaft; one lumen for high-pressure saline deliv-
ery which loops back re-directing flow through a gap into
the effluent lumen. This creates a localised low pressure
area which aspirates thrombus for fragmentation into
Selective pulmonary angiogram Figure 2
Selective pulmonary angiogram. Selective pulmonary 
angiogram revealing significant thrombus (labelled A) causing 
a central obstruction in the left main pulmonary artery. CTPA images Figure 1
CTPA images. CTPA images confirming the presence of a 
saddle embolus and substantial thrombus burden in the lobar 
branches of both main pulmonary arteries.Thrombosis Journal 2007, 5:20 http://www.thrombosisjournal.com/content/5/1/20
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small particles. The fragmented debris then pass into a
collection bag. There are disadvantages to the AngioJet
system that include a significant risk of fluid overload,
haemolysis, bradyarrhythmias, and the actual cost of the
pump-drive set.
Rheolytic thrombectomy to treat massive PE was first
described by Koning et al in 1997.[8] Despite their success
the use of PMT for massive PE in clinical practice has not
become widespread in the United Kingdom. This, in part,
can be attributed to a lack of expertise in this area and also
a lack of awareness as to the availability of this treatment
modality. The former statement can be misleading, how-
ever, since this was the first time our team had attempted
this procedure. In addition cases of massive PE are rare
and so it is difficult to ascertain what is best practice in
terms of local protocols.
The alternative to PMT is surgical embolectomy. This,
however, carries with it a high mortality and can be asso-
ciated with complications such as acute respiratory dis-
tress syndrome, acute renal failure, mediastinitis and
severe neurological sequelae. An experienced cardiac sur-
gical team is required and careful patient selection is nec-
essary for mortality and morbidity benefits to be borne
out.
Despite a lack of good quality randomised trials pointing
to mortality benefit thrombolysis remains the mainstay of
treatment for severe PE; either administered intravenously
or via catheter-directed means. When this is contraindi-
cated pulmonary catheterisation or surgical embolectomy
should be considered. This recommendation remains
anecdotal, however, since no trial evidence for PMT exists
and no randomised trial of medical versus surgical ther-
apy has ever taken place.[9,10] Hence the decision to go
with either alternative to thrombolysis has to be made on
a case-by-case basis and will depend on local availability
and expertise.
We have demonstrated that PMT via a rheolytic thrombec-
tomy catheter can be relatively straightforward in the
hands of a clinician experienced in endovascular proce-
dures. It can be a safe and effective means of clearing sig-
nificant thrombus burden from the pulmonary arterial
tree and can be considered a possible alternative to pul-
monary embolectomy when thrombolysis is relatively or
Selective pulmonary angiogram Figure 4
Selective pulmonary angiogram. Selective pulmonary 
angiogram revealing restoration of circulation to segmental 
arteries downstream of the left main pulmonary artery.
Selective pulmonary angiogram Figure 3
Selective pulmonary angiogram. Selective pulmonary 
angiogram showing percutaneous mechanical thrombectomy 
with the AngioJet catheter directed at the left main pulmo-
nary artery.Thrombosis Journal 2007, 5:20 http://www.thrombosisjournal.com/content/5/1/20
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absolutely contraindicated. PMT can also be used as an
adjuvant therapy prior to thrombolysis since fragmenta-
tion of the thrombus increases surface area making
thrombolytic infusion more successful. In the future fur-
ther evaluation involving a larger cohort of subjects is nec-
essary to determine whether this treatment is superior to




RCT: randomised controlled trial;
BTS: British Thoracic Society; 
CT: computed tomography; 
RCC: renal cell carcinoma;
CTPA: computed tomography pulmonary angiogram;
PMT: percutaneous mechanical thrombectomy;
F: French;
IVC: inferior vena cava;
MP-1: multipurpose-1.
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